Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wamin Group is an international pharmaceutical enterprise headquartered in Shanghai, China, specializing in the development, manufacturing, and distribution of high-quality generic medicines and medical devices. The company has established a significant footprint in emerging markets, particularly across Africa, where it operates through several regional subsidiaries and maintains a strong brand reputation. Wamin's extensive product portfolio encompasses a wide range of therapeutic areas, including antimalarials, anti-infectives, cardiovascular health, and analgesics. With multiple GMP-certified manufacturing facilities and a robust global supply chain, Wamin Group is dedicated to providing affordable and accessible healthcare solutions to regions with substantial medical needs. The company integrates its production capabilities with an extensive international logistics network to ensure the reliable delivery of essential medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wamin Group.